BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17849141)

  • 1. Considerations on occupational medical surveillance in employees handling nanoparticles.
    Nasterlack M; Zober A; Oberlinner C
    Int Arch Occup Environ Health; 2008 May; 81(6):721-6. PubMed ID: 17849141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational risk management of engineered nanoparticles.
    Schulte P; Geraci C; Zumwalde R; Hoover M; Kuempel E
    J Occup Environ Hyg; 2008 Apr; 5(4):239-49. PubMed ID: 18260001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered nanoparticles at the workplace: current knowledge about workers' risk.
    Pietroiusti A; Magrini A
    Occup Med (Lond); 2014 Jul; 64(5):319-30. PubMed ID: 25005544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science.
    Schulte PA; Trout D; Zumwalde RD; Kuempel E; Geraci CL; Castranova V; Mundt DJ; Mundt KA; Halperin WE
    J Occup Environ Med; 2008 May; 50(5):517-26. PubMed ID: 18469620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharpening the focus on occupational safety and health in nanotechnology.
    Schulte P; Geraci C; Zumwalde R; Hoover M; Castranova V; Kuempel E; Murashov V; Vainio H; Savolainen K
    Scand J Work Environ Health; 2008 Dec; 34(6):471-8. PubMed ID: 19137209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure assessment of workplaces manufacturing nanosized TiO2 and silver.
    Lee JH; Kwon M; Ji JH; Kang CS; Ahn KH; Han JH; Yu IJ
    Inhal Toxicol; 2011 Mar; 23(4):226-36. PubMed ID: 21456955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a medical surveillance program for animal care staff.
    Sharpe D
    Lab Anim (NY); 2009 Aug; 38(8):275-8. PubMed ID: 19626021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of medical surveillance in risk management.
    Nasterlack M
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S18-21. PubMed ID: 21606849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure monitoring of graphene nanoplatelets manufacturing workplaces.
    Lee JH; Han JH; Kim JH; Kim B; Bello D; Kim JK; Lee GH; Sohn EK; Lee K; Ahn K; Faustman EM; Yu IJ
    Inhal Toxicol; 2016; 28(6):281-91. PubMed ID: 27055369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workplace exposure to engineered nanoparticles.
    Plitzko S
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():25-9. PubMed ID: 19558230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for assessing workplace exposures to nanomaterials.
    Ramachandran G; Ostraat M; Evans DE; Methner MM; O'Shaughnessy P; D'Arcy J; Geraci CL; Stevenson E; Maynard A; Rickabaugh K
    J Occup Environ Hyg; 2011 Nov; 8(11):673-85. PubMed ID: 22023547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2011 Aug; 49(7):629-40. PubMed ID: 21861588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Multi-walled Carbon Nanotubes and Carbon Nanodiscs on Workplace Surfaces at a Small-Scale Producer.
    Hedmer M; Ludvigsson L; Isaxon C; Nilsson PT; Skaug V; Bohgard M; Pagels JH; Messing ME; Tinnerberg H
    Ann Occup Hyg; 2015 Aug; 59(7):836-52. PubMed ID: 26122528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational dermal exposure to nanoparticles and nano-enabled products: Part I-Factors affecting skin absorption.
    Larese Filon F; Bello D; Cherrie JW; Sleeuwenhoek A; Spaan S; Brouwer DH
    Int J Hyg Environ Health; 2016 Aug; 219(6):536-44. PubMed ID: 27289581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice.
    Kuempel ED; Geraci CL; Schulte PA
    Ann Occup Hyg; 2012 Jul; 56(5):491-505. PubMed ID: 22752094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workplace practices for engineered nanomaterial manufacturers.
    Woskie S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):685-92. PubMed ID: 20593453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalworking fluid mist occupational exposure limits: a discussion of alternative methods.
    Cohen H; White EM
    J Occup Environ Hyg; 2006 Sep; 3(9):501-7. PubMed ID: 16857649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle usage and protection measures in the manufacturing industry--a representative survey.
    Schmid K; Danuser B; Riediker M
    J Occup Environ Hyg; 2010 Apr; 7(4):224-32. PubMed ID: 20155559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology and health.
    Nanoparticle Task Force ACOEM
    J Occup Environ Med; 2011 Jun; 53(6):687-9. PubMed ID: 21293303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.